Cannabidiol (CBD): The Blurring Lines of Supplements, Foods and Pharma
29. Jul 2019•0 gefällt mir
1 gefällt mir
Sei der Erste, dem dies gefällt
Mehr anzeigen
•204 Aufrufe
Aufrufe
Aufrufe insgesamt
0
Auf Slideshare
0
Aus Einbettungen
0
Anzahl der Einbettungen
0
Downloaden Sie, um offline zu lesen
Melden
Daten & Analysen
Presentation from Supply Side West discussing the blurring lines of the supplement, food and pharmaceutical industries. Hemp and CBD market size and analysis included.
Green Hemp Acquistion: On closing, Canopy issued Green 24,576 common shares, valued at the time approximately USD630,000. Canopy may issue up to another 24,576 common shares if certain
production related milestones are achieved. The field operations alone are ready to scale from 600 acres in 2018 to 2,500 acres in 2019. To support this growth, custom built extraction infrastructure will be installed at Canopy's Tweed Grasslands facility.
Ebbu deal:
$19 million (at closing)
6,221,210 shares @ $50 = $311mm
$77mm earn out bonus
$19 million (at closing)
6,221,210 shares @ $50 = $311mm
$77mm earn out bonus